Evidence map›Paper›PMID 28318378›Full record

ReviewAutophagy2017

Pexophagy is responsible for 65% of cases of peroxisome biogenesis disorders.

Taras Y Nazarko

Open access · hybridAbstract readReview
In one paragraph

Review in Autophagy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Fluorescence Methods to Measure Pexophagy.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Taras Y Nazarkoa Section of Molecular Biology , Division of Biological Sciences, UC San Diego , La Jolla , CA , USA.
University of California, San Diego · US

Funding

Mechanisms of lipophagy, the selective autophagy of lipid dropletsR35GM119571 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NAZARKO, TARAS Y. · 2016 to 2020
$1.9M
Identification and validation of a lipophagy regulatorR03DK106344 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NAZARKO, TARAS Y. · 2015 to 2016
$155k
NIDDK NIH HHS R03 DK106344NIGMS NIH HHS R35 GM119571
6 · The paper itself

Abstract

Peroxisome biogenesis disorders (PBDs) is a group of diseases caused by mutations in one of the peroxins, proteins responsible for biogenesis of the peroxisomes. In recent years, it became clear that many peroxins (e.g., PEX3 and PEX14) play additional roles in peroxisome homeostasis (such as promoting autophagic degradation of peroxisomes or pexophagy), which are often opposite to their originally established functions in peroxisome formation and maintenance. Even more interesting, the peroxins that make up the peroxisomal AAA ATPase complex (AAA-complex) in yeast (Pex1, Pex6 and Pex15) or mammals (PEX1, PEX6, PEX26) are responsible for the downregulation of pexophagy. Moreover, this might be even their primary role in human: to prevent pexophagy by removing from the peroxisomal membrane the ubiquitinated peroxisomal matrix protein import receptor, Ub-PEX5, which is also a signal for the Ub-binding pexophagy receptor, NBR1. Remarkably, the peroxisomes rescued from pexophagy by autophagic inhibitors in PEX1

Indexed as

AnimalsAutophagyHumansIntracellular MembranesPeroxisomal DisordersPeroxisomesProtein TransportUbiquitinUbiquitinATPaseperoxinperoxisomeperoxisome biogenesis disorderPEX1PEX15PEX26PEX5PEX6pexophagy

Identifiers

PMID28318378
PMCPMC5446054
OpenAlexW2600143897

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.